Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

The global cardiac marker testing market was valued at approximately USD 4.02 billion in 2022 and is expected to grow at a CAGR of 9.4% from 2023 to 2030. Cardiac marker testing involves the analysis ...

Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.

Delayed diagnosis is a serious issue in modern medicine. Explore conditions that are frequently diagnosed too late or ...

Liberal blood transfusion after heart attack in patients with kidney disease (CKD) is not harmful, according to study results.

Jacob Temple is warning people about the health consequences of e-cigarettes, saying he now has the lungs of a 70-year-old ...

A myocardial infarction, commonly known as a heart attack, remains one of the leading causes of illness and death worldwide.When one occurs, part of the heart muscle is deprived of oxygen due to a ...

Heart attacks are no longer the leading cause of heart disease-related death, but deaths from heart disease have still been ...

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

Myocardial infarction or 'heart attack' is a type of acute coronary syndrome in which sudden blockage of a coronary artery, and subsequent myocardial ischaemia, results in damage to the ...

New data highlight a substantial decline in overall heart disease death rates during the past 50 years, along with a shift in ...